drugset / Trial / NCT01096290
Comparison of Lubiprostone and Placebo for the Relief of Constipation From Constipating Medications
Phase 4
Terminated
23 enrolled
University of South Alabama
Sucampo Pharmaceuticals, Inc. · collabTakeda · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
Constipation from medications is a serious and common condition. Lubiprostone has properties that make it a candidate drug. One hundred volunteers with constipation who are taking medications known to cause constipation will be randomized to take lubiprostone or placebo for 28 days. Therapeutic outcome will be evaluated by investigator and study subject assessment.
Timeline
- Start
- 2010-04
- Primary completion
- 2012-09
- Completion
- 2012-09
Outcome
Outcome not reported
Stopped: “Number of needed participants could not be obtained”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lubiprostone | Small molecule | 24 ug | Oral |